Treatment of hepatic and pulmonary hydatidosis with albendazole and praziquantel
By: G. Popova, D. Vuchev and K. Anichina
References
- A
lvela -Suárez , L., Velasco -Tirado , V., Belhassen -Garcia , M., Novo -Veleiro , I., Pardo -Lledias , J., Romero -Alegría , A, Pérez del Villar , L., Valverde -Merino , M.P., Cordero -Sánchez , M. (2014): Safety of the Combined Use of Praziquantel and Albendazole in the Treatment of Human Hydatid Disease. Am J Trop Med Hyg, 90(5): 819 – 822. DOI: 10.4269/ajtmh.13-0059 - A
yles , H.M., Corbett , E.L., Taylor , I., Cowie , A.G., Bligh , J, Walmsley , K., Bryceson , A.D. (2002): A combined medical and surgical approach to hydatid disease: 12 years of experience at the Hospital for Tropical Diseases, London. Ann R Coll Surg Engl, 84(2): 100 – 105 - B
onifacino , R., Carter , S., Craig , P., Almeida , I., Da Rosa , D. (2000): Assessment of the immunological surveillance value of humoral and lymphocyte assays in severe human cystic echinococcosis. Trans R Soc Trop Med Hyg, 94(1): 97 – 102. DOI: 10.1016/s0035-9203(00)90455-3 - B
runetti , E., Kern P., Vuitton , D.A., Writing Panel for the WHO-IWGE. (2010): Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop, 114 (1): 1 – 16. DOI: 10.1016/j.actatropica.2009.11.001 - B
ygott , J.M., Chiodini , P.L. (2009): Praziquantel: Neglected drug? Ineffective treatment? Or therapeutic choice in cystic hydatid disease? Acta Trop, 111(2): 95 – 101. DOI: 10.1016/j.actatropica.2009.04.006 - C
obo , F., Yarnoz , C., Sesma , B., Fraile , P., Aizcorbe , M., Trujillo , R., Diaz -De -Liaño , A., Ciga , M.A. (1998): Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatidosis caused by Echinococcus granulosus. Trop Med Int Health, 3(6): 462 – 466. DOI: 10.1046/j.1365-3156.1998.00257.x - E
uropean Centre for Disease Prevention and Control . (2022): Echinococcosis. In: ECDC. Annual epidemiological report for 2020. Stockholm: ECDC - H
aralabidis , S., Diakou , A., Frydas , S., Papadopoulos , E., Mylonas , A., Patsias , A., Roilides , E., Giannoulis , E. (2008): Long-term evaluation of patients with hydatidosis treated with albendazole and praziquantel. Int J Immunopathol Pharmacol, 21(2): 429 – 435. DOI: 10.1177/039463200802100223 - H
omeida , M., Leahy , W., Copeland , S., Ali , M.M., Harron , D.W. (1994): Pharmacokinetic interaction between praziquantel and albendazole in Sudanese men. Ann Trop Med Parasitol, 88(5): 551 – 559. DOI: 10.1080/00034983.1994.11812903 - J
amshidi , M., Mohraz , M., Zangeneh , M., Jamshidi , A. (2008): The effect of combination therapy with albendazole and praziquantel on hydatid cyst treatment. Parasitol Res, 103(1): 195 – 199. DOI: 10.1007/s00436-008-0954-z - K
ern , P. (2006): Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH). Parasitol Int, 55 Suppl:S273 – S282. DOI: 10.1016/j.parint.2005.11.040 - L
ima , R.M., Ferreira , M.A.,de Jesus Ponte Carvalho , T.M., Dumêt Fernandes , B.J., Takayanagui , O.M., Garcia , H.H., Coelho , E.B., Lanchote , V.L. (2011): Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity. Br J Clin Pharmacol, 71(4): 528 – 535. DOI: 10.1111/j.1365-2125.2010.03874.x - L
ötsch , F., Naderer , J., Skuhala , T., Groger , M., Auer , H. Kaczirek , K., Waneck , F., Ramharter , M. (2016): Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data. Parasitol Res, 115 (8): 2995 – 3001. DOI: 10.1007/s00436-016-5054-x - M
asoom , S., Lari , S., Fattahi , A., Ahmadnia , N., Rajabi , M., Naderi Kalat , M. (2018): Albendazole therapy in human lung and liver hydatid cysts: A 13-year experience. Clin Respir J, 12(3): 1076 – 1083. DOI: 10.1111/crj.12630 - M
cmanus , D., Zhang , W., Li , J., Bartley , P.B. (2003): Echinococcosis. Lancet, 362(9392): 1295 – 1304. DOI: 10.1016/S0140-6736(03)14573-4 - M
ohamed , A., Yasawy , M., Karawi , M. (1998): Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology, 45(23): 1690 – 1694 - M
oro , P., Schantz P. M. (2009): Echinococcosis: a review. Int J Infect Dis, 13(2): 125 – 133. DOI: 10.1016/j.ijid.2008.03.037 - N
azligul , Y., Kucukazman , M., Akbulut , S. (2015): Role of Chemotherapeutic Agents in the Management of Cystic Echinococcosis. Int Surg, 100(1): 112 – 114. DOI: 10.9738/INTSURG-D-14-00068.1 - N
unnari , G., Pinzone , M. R, Gruttadauria , S., Celesia , B. M, Madeddu , G., Malaguarnera , G, Pavone , P., Cappellani , A., Cacopardo , B. (2012): Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol, 18(13): 1448 – 1458. DOI: 10.3748/wjg.v18.i13.1448 - R
ainova , I.G., Harizanov , R.N., Tsvetkova , N.D., Kaftandjiev , I.T., Enikova , R.B., Ivanova , M., Videnova , M.V., Kaneva , E.M., Mikov , O.D. (2022): Epidemiological Indicators of the State of Cystic Echinococcosis in Republic of Bulgaria for the Period 2011 – 2020. Int J Echinococcoses, 1(2): 26 – 32. DOI: 10.5455/IJE.2022.03.05 - S
alinas , J., Gonzales , H., Astuvilca , J., Arce -Villavicencio , Y., Carbajal -Gonzalez , D., Talledo , L., Willig , J.H. (2011): Long-term albendazole effectiveness for hepatic cystic echinococcosis. Am J Trop Med Hyg, 85(6): 1075 – 1079; DOI: 10.4269/ajtmh.2011.11-0382 - S
mego , R.A., Sebanego , P. (2005): Treatment options for hepatic cystic echinococcosis. Int J Infect Dis, 9(2): 69 – 76. DOI: 10.1016/j.ijid.2004.08.001 - S
tojković , M., Weber , T., Junghanss , T. (2018): Clinical management of cystic echinococcosis: state of the art and perspectives. Curr Opin Infect Dis, 31(5): 383 – 392. DOI: 10.1097/QCO.0000000000000485 - V
elasco -Tirado , V., Alonso -Sardón , M., Lopez -Bernus , A., Romero -Alegría , Á., Javier Burguillo , F.J., Muro , A., Carpio -Pérez , A., Muñoz Bellido , J.L., Pardo -Lledias , J., Cordero , M. et al. (2018): Medical treatment of cystic echinococcosis: systematic review and meta-analysis. BMC Infect Dis, 18(1): 306. DOI: 10.1186/s12879-018-3201-y - V
uitton , D.A. (2009): Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus? Expert Rev Anti Infect Ther, 7(2): 145 – 149. DOI: 10.1586/14787210.7.2.145 - W
en , H., Vuitton , L., Tuxun , T., Li , J., Vuitton , D.A., Zhang , W., Mc Manus , D.P. (2019): Echinococcosis: advances in the 21st century. Clin Microbiol Rev, 32(2): e00075–18. DOI: 10.1128/CMR.00075-18 - WHO I
nformal Working Group on Echinococcosis . (1996): Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull WHO, 74: 231 – 242 - WHO I
nformal Working Group on Echinococcosis . (2003): International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop, 85(2): 253 – 261. DOI: 10.1016/s0001-706x(02)00223-1
Language: English
Page range: 221 - 226
Submitted on: Jan 26, 2023
Accepted on: Jul 27, 2023
Published on: Dec 26, 2023
Published by: Slovak Academy of Sciences, Institute of Parasitology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Keywords:
Related subjects:
© 2023 G. Popova, D. Vuchev, K. Anichina, published by Slovak Academy of Sciences, Institute of Parasitology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.